Kadish H A, Loveridge B, Tobey J, Bolte R G, Corneli H M
Department of Pediatrics, Primary Children's Medical Center, Salt Lake City, Utah 84113, USA.
Clin Pediatr (Phila). 2000 Feb;39(2):81-8. doi: 10.1177/000992280003900202.
The purpose of this study was to determine the applicability of two accepted outpatient management protocols for the febrile infant 1-2 months of age (Boston and Philadelphia protocols) in febrile infants 1-28 days of age. We retrospectively reviewed charts of patients 1-28 days of age with a temperature greater than or equal to 38.0 degrees C. Criteria from each of the above-cited management protocols were applied to the patients to determine their applicability in screening for serious bacterial infection (SBI). An SBI was defined as bacterial growth in cultures from blood, urine, cerebrospinal fluid (CSF), stool, or any aspirated fluid. Overall, 372 febrile infants were included in the study. Ages ranged from 1 to 28 days of age. The mean age was 15 days. SBI occurred in 45 patients (12%). The mean age of the patients with an SBI was 13 days. Thirty-two infants (8.6%) had a urinary tract infection; 12 (3.2%), bacteremia; five (1.3%), bacterial meningitis; three (0.8%), cellulitis; one (0.3%), septic arthritis; one (0.3%), bacterial gastroenteritis; and one (0.3%), pneumonia. Ten infants had more than one SBI. Of 372 patients, 231 (62%) met the Boston's laboratory low-risk criteria; eight (3.5%) would have been sent home with an SBI with these criteria. Philadelphia's laboratory low-risk criteria would have been met by 186 patients (50%); six (3.2%) would have been sent home with an SBI with these criteria. The negative predictive value of both the Boston and Philadelphia protocols for excluding an SBI was 97%. We conclude that current management protocols for febrile infants 1-2 months of age when applied to febrile infants 1 to 28 days of age would allow 3% of febrile infants less than 28 days of age to be sent home with an SBI. Current guidelines recommending admitting all febrile infants less than 28 days of age should be followed until the outcome of those 3% of febrile infants with an SBI treated as outpatients can be determined.
本研究的目的是确定两种已被认可的针对1至2个月大发热婴儿的门诊管理方案(波士顿方案和费城方案)在1至28天大的发热婴儿中的适用性。我们回顾性地查阅了年龄在1至28天、体温大于或等于38.0摄氏度的患者病历。将上述每种管理方案的标准应用于这些患者,以确定其在筛查严重细菌感染(SBI)方面的适用性。SBI被定义为血液、尿液、脑脊液(CSF)、粪便或任何吸出液培养中的细菌生长。总体而言,372名发热婴儿被纳入研究。年龄范围为1至28天。平均年龄为15天。45名患者(12%)发生了SBI。发生SBI的患者平均年龄为13天。32名婴儿(8.6%)患有尿路感染;12名(3.2%)患有菌血症;5名(1.3%)患有细菌性脑膜炎;3名(0.8%)患有蜂窝织炎;1名(0.3%)患有化脓性关节炎;1名(0.3%)患有细菌性胃肠炎;1名(0.3%)患有肺炎。10名婴儿患有不止一种SBI。在372名患者中,231名(62%)符合波士顿实验室低风险标准;按照这些标准,8名(3.5%)患有SBI的婴儿会被送回家。186名患者(50%)符合费城实验室低风险标准;按照这些标准,6名(3.2%)患有SBI的婴儿会被送回家。波士顿和费城方案排除SBI的阴性预测值均为97%。我们得出结论,目前针对1至2个月大发热婴儿的管理方案应用于1至28天大的发热婴儿时,会使3%不到28天大的发热婴儿在患有SBI的情况下被送回家。在确定这3%作为门诊患者治疗的患有SBI的发热婴儿的结局之前,应遵循目前建议收治所有不到28天大发热婴儿的指南。